Veracyte | VCYT - Ebit

Stock Price
32.28
Daily Change
0.03 0.09%
Monthly
-3.27%
Yearly
9.31%
Q2 Forecast
31.28

Veracyte reported $24.63M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agenus USD 14.4M 19.26M Dec/2025
Agilent USD 353M 90M Dec/2025
Anika Therapeutics USD 646K 3.88M Dec/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
Bruker USD 76.3M 7.6M Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Illumina USD 256M 6M Dec/2025
Intrexon USD -26.3M 2.91M Jun/2024
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
Laboratory Of America USD 382M 11M Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Rigel Pharmaceuticals USD 447K 1.52M Jun/2024
Roche Holding CHF 9.56B 2.1B Dec/2025
Siemens EUR 2.57B 3M Dec/2025
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 24.63M 1.52M Dec/2025
Waters USD 270.52M 78.4M Dec/2025